Research Article
GABPA Expression in Endometrial Carcinoma: A Prognostic Marker
Table 4
Clinicopathologic characteristics.
| | Characteristic | | (%) |
| | Age(year) | | | | Histology | | | | Endometrioid | 88 | 82.24 | | Serous | 13 | 12.15 | | Mixed serous and endometrioid | 6 | 5.61 | | Myometrial invasion | | | | <50% | 71 | 66.36 | | ≥50% | 36 | 33.64 | | Cervical invasion | | | | Negative | 97 | 90.65 | | Positive | 10 | 9.35 | | Lymph nodes | | | | Negative | 92 | 85.98 | | Positive | 15 | 14.02 | | Grade | | | | G1 | 47 | 43.93 | | G2 | 36 | 33.64 | | G3 | 24 | 22.43 | | Stage | | | | I | 85 | 79.44 | | II | 3 | 2.80 | | III | 18 | 16.82 | | IV | 1 | 0.94 | | Surgical approach | | | | Open | 98 | 91.60 | | Minimally invasive | 9 | 8.40 | | GABPA expression | | | | Low | 64 | 59.81 | | High | 43 | 40.19 |
|
|
Age: age of endometria carcinoma diagnosis; GABPA: GA-binding protein A.
|